Schedule 13G ownership disclosure

REATA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 75615P103

Event date: 2017-07-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
720,937
Percent of class
4.8800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-051397
Form type
SC 13G/A
Filer
AbbVie Inc.
CIK
CIK 1551152
Filed
Aug 11, 2017
Reporting period
Jul 25, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub